Trial · NCT03608371
Results by group85
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 85
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maximal Change in UPDRS Part III From Predose to Postdose on Day 1 | BTRX-246040 Cohort 1 | -22.0 | Standard Deviation 7.01 | score on a scale | |
| Maximal Change in UPDRS Part III From Predose to Postdose on Day 1 | BTRX-246040 Cohort 2 | -12.5 | Standard Deviation 4.68 | score on a scale | |
| Maximal Change in UPDRS Part III From Predose to Postdose on Day 1 | BTRX-246040 Cohort 3 | -11.2 | Standard Deviation 3.92 | score on a scale | |
| Maximal Change in UPDRS Part III From Predose to Postdose on Day 1 | Combined BTRX-246040 | -15.2 | Standard Deviation 7.08 | score on a scale | |
| Maximal Change in UPDRS Part III From Predose to Postdose on Day 1 | Placebo | -17.0 | Standard Deviation 12.07 | score on a scale | |
| Duration of ON Time on Day 1 | BTRX-246040 Cohort 1 | 2.983 | Standard Deviation 1.8144 | hours | |
| Duration of ON Time on Day 1 | BTRX-246040 Cohort 2 | 3.750 | Standard Deviation 1.8484 | hours | |
| Duration of ON Time on Day 1 | BTRX-246040 Cohort 3 | 4.000 | hours | ||
| Duration of ON Time on Day 1 | Combined BTRX-246040 | 3.494 | Standard Deviation 1.6095 | hours | |
| Duration of ON Time on Day 1 | Placebo | 4.250 | Standard Deviation 1.5000 | hours | |
| Percentage of Participants Who Turned ON on Day 1 | BTRX-246040 Cohort 1 | 6 | Participants | ||
| Percentage of Participants Who Turned ON on Day 1 | BTRX-246040 Cohort 2 | 6 | Participants | ||
| Percentage of Participants Who Turned ON on Day 1 | BTRX-246040 Cohort 3 | 4 | Participants | ||
| Percentage of Participants Who Turned ON on Day 1 | Combined BTRX-246040 | 16 | Participants | ||
| Percentage of Participants Who Turned ON on Day 1 | Placebo | 5 | Participants | ||
| Time to ON on Day 1 | BTRX-246040 Cohort 1 | 3.575 | Standard Deviation 2.7749 | hours | |
| Time to ON on Day 1 | BTRX-246040 Cohort 2 | 2.583 | Standard Deviation 2.7462 | hours | |
| Time to ON on Day 1 | BTRX-246040 Cohort 3 | 3.646 | Standard Deviation 2.7742 | hours | |
| Time to ON on Day 1 | Combined BTRX-246040 | 3.221 | Standard Deviation 2.6231 | hours | |
| Time to ON on Day 1 | Placebo | 3.200 | Standard Deviation 2.8417 | hours |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03608371/results